Alzheimer's disease in Down syndrome: neurobiology and risk.
about
Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndromeAir pollution, oxidative stress, and Alzheimer's diseasePeriodontal disease's contribution to Alzheimer's disease progression in Down syndromeBuilding an adaptive brain across development: targets for neurorehabilitation must begin in infancyOxidative stress, thyroid dysfunction & Down syndromePain perception in people with Down syndrome: a synthesis of clinical and experimental researchEmerging roles for intersectin (ITSN) in regulating signaling and disease pathwaysNeurological phenotypes for Down syndrome across the life spanEffects of neonatal neural progenitor cell implantation on adult neuroanatomy and cognition in the Ts65Dn model of Down syndromeNeuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?Healthcare and guidelines: a population-based survey of recorded medical problems and health surveillance for people with Down syndrome.NPTX2 and cognitive dysfunction in Alzheimer's Disease.Molecular basis of pharmacotherapies for cognition in Down syndromeLanguage Characteristics of Individuals with Down Syndrome.Deficits in human trisomy 21 iPSCs and neurons.Down's syndrome and Alzheimer's disease: towards secondary prevention.Protein aggregation and degradation mechanisms in neurodegenerative diseasesCatatonia in Down syndrome; a treatable cause of regressionCaregiver report of executive functioning in a population-based sample of young children with Down syndrome.Ophthalmic disorders in adults with down syndrome.Intersectin 1 contributes to phenotypes in vivo: implications for Down's syndrome.Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementiaAntagonism of NMDA receptors as a potential treatment for Down syndrome: a pilot randomized controlled trial.Mild cognitive impairment identified in older individuals with Down syndrome by reduced telomere signal numbers and shorter telomeres measured in micronsRapid assessment of cognitive function in down syndrome across intellectual level and dementia status.Targeting protein aggregation for the treatment of degenerative diseasesQuantitative Electroencephalography as a Diagnostic Tool for Alzheimer's Dementia in Adults with Down Syndrome.The state of the science of health and wellness for adults with intellectual and developmental disabilitiesOverexpression of amyloid-β protein precursor induces mitochondrial oxidative stress and activates the intrinsic apoptotic cascadeAn Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome.Down syndrome and Alzheimer's disease: Common pathways, common goals.Dissociations in Cortical Morphometry in Youth with Down Syndrome: Evidence for Reduced Surface Area but Increased ThicknessDown's syndrome and myocardial reperfusion injury.Alzheimer's Disease in Adults with Down SyndromeUsp16 contributes to somatic stem-cell defects in Down's syndrome.Vision deficits in adults with Down syndromeEvent-related potential index of age-related differences in memory processes in adults with Down syndrome.Dementia and mild cognitive impairment in adults with intellectual disability: issues of diagnosis.Atypical aging in Down syndrome.Dementia in people with intellectual disability: insights and challenges in epidemiological research with an at-risk population.
P2860
Q21136371-A8CB99A5-5928-41EC-85D9-8E7F3651C48CQ21285060-216C4B45-2012-4980-BB8D-C264BA55ABF8Q26744852-472B26ED-56AA-4277-9C8C-FBA1F99EEDFCQ26781609-4F4B47FD-759A-4A9E-8AB0-AC54A8C08C14Q26782125-D0E6982F-EBCE-4142-8171-5D9F239E5AD5Q26797391-7A11A556-FF0D-4A8A-BEEC-064275EF5C7EQ26824407-F2DB9A3C-8FFB-43B2-89A7-2CB942D2B6FAQ27025698-91C0C771-E20C-47F0-A4E3-75F160242306Q27303804-AB62A22A-5258-41EC-B2FE-501B10E70205Q28070156-BC52599E-10A0-48BC-984C-ABE157FF2EC8Q33159950-F9B6CDA7-2B9F-46E1-BD17-5636D76C61C5Q33602969-7D8BB534-A3F6-4027-996C-A4EF453CBE4AQ33625613-B83F5934-7E54-450C-9252-F570C434995DQ33813197-F980EF57-1998-452B-971C-DF3CE0E3D67AQ34036957-8B435BC9-E9F9-4069-ACBB-3D6315B73DFCQ34296806-C5D4F403-958C-49B8-BA6C-DAB1D8F803D3Q34334363-6CBFA825-DDF4-4603-8092-530B72FF78CEQ35411330-8AE92ED1-052E-4D03-9F38-976766FDEECBQ35882631-7E61DD52-11DE-4C5E-9952-63F49B66B1D8Q35915355-F02912F6-AA0A-4688-8B5F-014EA9BA3FD0Q35921272-7B90DB87-B811-4010-8AC2-6FB12AC7C46FQ35977798-0237B01E-2A38-479B-BB14-15C890237E2BQ36137301-4B31E72E-B013-492F-A827-007AC2AA3343Q36153435-95D9C5A4-C822-4050-AFD2-DD153BFE49ECQ36217929-6530BDEB-78EF-4744-9EDA-C3CB8BC41FE3Q36235980-35D5F20D-6ED4-4511-BA6A-CAB51BD0507EQ36325825-675B10E8-F34B-4306-A508-C9A4B562E48EQ36368030-871AB258-FD48-4003-8903-82155B80FC53Q36371958-17355ECF-D03A-4B94-A1E3-248F60B4D249Q36739111-C6F07B4D-806A-4B88-88EB-670688CF9557Q36757252-FA75174A-C8A5-49EA-BA29-F10C19F4DCD2Q36982868-7CAE4A3A-69F7-4981-B309-7C6438D0EFB9Q37055926-AAC0407F-4A62-43A7-B2BD-5B2D344F5DC4Q37272133-59B6FAEB-1DFE-4530-B7DA-3EA7C338D085Q37278288-3BD82AB5-940F-40B1-A0A9-8AD485E8658DQ37344569-4A02AD9F-4883-4DF1-BC86-24D9F6CAA435Q37362095-B598DD3C-C7F2-4F98-8E0A-B85D07D1B109Q38129323-7BDD0066-4441-4A47-A84D-2AADFEFD7AD0Q38129325-BDF3BC8E-3D9E-46E3-831C-FE1D5B42AC8EQ38178376-DB66D592-8557-4A8D-AF01-963AEE959945
P2860
Alzheimer's disease in Down syndrome: neurobiology and risk.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Alzheimer's disease in Down syndrome: neurobiology and risk.
@en
type
label
Alzheimer's disease in Down syndrome: neurobiology and risk.
@en
prefLabel
Alzheimer's disease in Down syndrome: neurobiology and risk.
@en
P2860
P356
P1476
Alzheimer's disease in Down syndrome: neurobiology and risk
@en
P2093
Ira T Lott
P2860
P304
P356
10.1002/MRDD.20163
P577
2007-01-01T00:00:00Z